IDEXX Laboratories, Inc. (NASDAQ:IDXX) Weekly Ratings on May 16, 2018

May 16, 2018 - By Matthew Richard

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Corporate Logo
Big Money Sentiment decreased to 0.81 in 2017 Q4. It has change of 0.05, from 2017Q3’s 0.86. The ratio turned negative due to IDEXX Laboratories, Inc. positioning: 30 sold and 217 reduced. 64 funds bought positions and 137 increased positions. Investors holded 87.85 million in 2017Q3 but now own 72.13 million shares or 17.89% less.
Carderock Management holds 2.45% or 35,490 shs. Janney Montgomery Scott Limited Company reported 4,874 shs. Employees Retirement System Of Texas reported 4,000 shs. Teachers Retirement Systems Of The State Of Kentucky owns 11,500 shs. Chesley Taft And Associate Lc reported 5,248 shs or 0.07% of all its holdings. Van Eck Corp holds 0.12% or 159,847 shs. Art Advsr Llc invested in 0.09% or 13,300 shs. Winslow Evans And Crocker Incorporated accumulated 0.05% or 1,000 shs. Great West Life Assurance Can stated it has 62,307 shs. First Interstate Bancorporation has 0.01% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 450 shs. Cibc World Mkts reported 0.03% stake. Clearbridge Invests Ltd Company, a New York-based fund reported 63,451 shs. Sector Pension Inv Board holds 4,629 shs or 0% of its capital. Mitsubishi Ufj Tru And Banking invested in 184,971 shs or 0.05% of the stock. State Treasurer State Of Michigan holds 25,600 shs or 0.03% of its capital.

IDEXX Laboratories, Inc. had 7 insider sales and 2 buys since January 9, 2018. This’s net activity of $23.44 million. On Monday, February 5 MCKEON BRIAN P had sold 6,602 shs worth $1.20M. On Wednesday, February 7 Shares for $3.91M were sold by AYERS JONATHAN W. The insider Kingsley Lawrence D bought $178,045. $565,232 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was sold by JUNIUS DANIEL M. Claflin Bruce L. bought 1,000 shs worth $179,580.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings Coverage

In total 5 analysts cover IDEXX Laboratories (NASDAQ:IDXX). “Buy” rating has 5, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 7 are the (NASDAQ:IDXX)’s analyst reports since January 16, 2018 according to StockzIntelligence Inc. On Monday, January 29 Canaccord Genuity maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) rating. Canaccord Genuity has “Buy” rating and $210.0 target. On Monday, May 7 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Buy” rating given by Canaccord Genuity. On Thursday, February 1 the firm earned “Buy” rating by Stifel Nicolaus. On Friday, February 2 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Bank of America. On Monday, May 7 the company was maintained by Stifel Nicolaus. Listed here are IDEXX Laboratories, Inc. (NASDAQ:IDXX) PTs and latest ratings.

07/05/2018 Broker: Canaccord Genuity Rating: Buy New Target: $225.0000 Maintain
07/05/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $215 New Target: $225 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $200 New Target: $220 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $215.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $211.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $210.0 Maintain
16/01/2018 Broker: PiperJaffray Rating: Overweight New Target: $200 Initiates Coverage On

IDXX hit $199.54 during the last trading session after $9.38 change.IDEXX Laboratories, Inc. is uptrending after having risen 23.99% since May 16, 2017. IDXX has 1.12 million volume or 139.04% up from normal. IDXX outperformed the S&P 500 by 12.44%.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.The firm is worth $17.33 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions.The P/E ratio is 67.87. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

More recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were released by Seekingalpha.com, Fool.com and Nasdaq.com. The first one has “Buy Diamondback Energy On Declines – Cramer’s Lightning Round (5/11/18)” as a title and was released on May 14, 2018. The next is “The 3 Stocks on the MFM Team’s Radar This Week” on May 10, 2018. And last was released on May 11, 2018, called “IDEXX Laboratories Barks Out Another Successful Quarter”.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.